Skip Navigation


Paul D. Savage, M.D.Wake Forest Baptist Health

Doctor Rating

4.5 out of 5

150 Ratings

Paul D. Savage, M.D.

Associate Professor,

Clinical Interests

Sarcoma, Mesothelioma, Thyroid Disease, Melanoma, Skin Cancer

Contact Information

Returning Patient Appointments: 336-713-5440
Department: 336-716-4464

Insurance Accepted »

Education & Training

  • B.S., Tufts University, 1977
  • M.D., Tufts University School of Medicine, 1981
  • Internship, Internal Medicine, Rush-Presbyter-St Lukes Mc, 1982
  • Residency, Internal Medicine, Rush-Presbyter-St Lukes Mc, 1984
  • Fellowship, U Minnesota Affil Hosps, 1989

Board Certifications

  • American Board of Internal Medicine, Internal Medicine


  • Am Assn for Cancer Research
  • Am Coll Of Physicians
  • Am Soc of Clinical Oncology
  • Am Soc of Hematology
  • Connective Tissue Oncology Soc

NPI Number

  • 1306938261
Paul D. Savage, M.D.

Doctor Rating

4.5 out of 5

150 Ratings

Paul D. Savage, M.D.

Associate Professor, Hematology & Oncology

Research Interests

Neoplasms, Muscle Tissue; Bone Marrow Neoplasms; Antineoplastic Agents; Gastrointestinal Neoplasms; Protein-Tyrosine Kinases
More »

Contact Information

Academic: 336-716-7975 | Department: 336-716-4464

Recent Publications

Biology and treatment of metastasis of sarcoma to the brain. Ahmad O, Chan M, Savage P, Watabe K, Lo HW, Qasem S.. Front Biosci (Elite Ed). 2016;8():233-244.

Serum calcium, albumin and tumor stage in cutaneous malignant melanoma. Datta M, Savage P, Lovato J, Schwartz GG.. Future Oncol. 2016;12(19):2205-2214.

Outcomes for metastatic melanoma treated with stereotactic radiosurgery in the era of targeted systemic therapies [abstract]. Henson A, McTyre E, Ayala-Peacock DN, Triozzi P, Savage P, Laxton AW, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E135-E136.

Phase II trial of angiotensin-(1-7) for the treatment of patients with metastatic sarcoma. Savage PD, Lovato J, Brosnihan KB, Miller AA, Petty WJ.. Sarcoma. 2016;2016():4592768.

Reverse translation of phase I biomarker findings links the activity of angiotensin-(1-7) to repression of hypoxia inducible factor-1alpha in vascular sarcomas. Petty WJ, Aklilu M, Varela VA, Lovato J, Savage PD, Miller AA.. BMC Cancer. 2012;12():404.

Phase I study of lenalidomide in solid tumors. Miller AA, Case D, Harmon M, Savage P, Lesser G, Hurd D, Melin SA.. J Thorac Oncol. 2007;2(5):445-449.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Hematology & Oncology

Clinical Interests

Sarcoma, Mesothelioma, Thyroid Disease, Melanoma, Skin Cancer
Paul D. Savage, M.D.

Paul D. Savage, M.D.

Associate Professor, Hematology & Oncology

Doctor Rating

4.5 out of 5

Paul D. Savage, M.D.150 Ratings


Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
CP efforts to include in decisions
CP explanations of prob/condition
CP spoke using clear language
Friendliness/courtesy of CP
Likelihood of recommending CP
Patients' confidence in CP
Time CP spent with patient
Wait time at clinic

Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.


All were very helpful.


We are very involved in our Dad's care. We are made to feel like we should not be asking questions. Last time answers were given to us in harsh & loud voice. We just quit asking.


Very professional, very personable just a great doctor.




It was not a bad experience.


I have lots of confidence in Dr Savage. I feel very fortunate that he is the physician who oversees my oncology care!


In my 20 years of seeing *Dr. Lavage there has never been a negative visit.


I feel fortunate to have been referred to *Dr. Savage for care. Thankful he is at the Wake Forest Medical Ctr. as this is more convenient than having to go further. Being out of state, I must travel quite a distance. *Melissa _______, P.C., of this office is excellent.


Never saw the provider. Two hour drive to clinic. Hour & half wait and was told go set up 6 month appointment.


*Dr.Savage is a very knowledgeable experienced doctor and most professional with excellent knowledge of his profession. The last APPOINTMENT WAS a SIX MONTH FOLLOW UP FUTURE APPOINTMENT is SCHEDULE for 1 YEAR.


Wonderful physician.


Dr. Savage is a true Mensch :-)


I consider myself very fortunate to have Dr. Savage as my oncologist. He has treated me in this capacity since 2003, so I have had many opportunities to observe his impeccable manner with me as a patient, his ability to explain complicated cancer illnesses and treatments in a straightforward and understandable way, and his genuine concern for the welfare of his patients.


*Dr. Paul Savage MD and the others provider very good.


Dr Savage gave a most brilliant presentation on chemotherapy, i learned as much as if i were in a college class!

Quick Reference

Request an Appointment
New Patients


Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Five Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is RenewedMagnet Hospital Recognition2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.